CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 1 Safety and Efficacy Study of ADI-001 Anti-CD20 CAR-engineered Allogeneic Gamma Delta (γδ) T Cells in Adults With B Cell Malignancies
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04735471
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:40.773308+00:00
- Published At
- 2025-06-18T00:00:00+00:00
- Record Updated At
- 2025-06-18
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Lymphoma, Follicular", "Lymphoma, Mantle-Cell", "Marginal Zone Lymphoma", "Primary Mediastinal B-cell Lymphoma", "Diffuse Large B Cell Lymphoma", "Lymphoma, Non-Hodgkin"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-06-18"- protocolSection.identificationModule.nctId
"NCT04735471"- protocolSection.identificationModule.officialTitle
"A Phase 1 Safety and Efficacy Study of ADI-001 Anti-CD20 CAR-engineered Allogeneic Gamma Delta (\u03b3\u03b4) T Cells in Adults With B Cell Malignancies"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.